ImmVirX
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hmri Building L 2, New Lambton Heights, ...Website
www.immvirx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ImmVirX
ImmVirX is a provider of immuno-oncology company using proprietary bio-selected RNA viruses that target specific receptor proteins highly expressed on a range of cancer cell types, allowing them to selectively enter, replicate in, and destroy tumor cells while creating beneficial changes in the tumor micro-environment.Explore more
ImmVirX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ImmVirX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ImmVirX had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ImmVirX
Product Launch: Get notified when ImmVirX launches new products
Earning: See what the market has to say on ImmVirX recently announced quarterly report
Check if ImmVirX has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ImmVirX has new funding data
ImmVirX, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ImmVirX is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined ImmVirX as Masked Content
Find 3 more new buyers
Compare Similar Companies to ImmVirX
Compare insights from companies similar to ImmVirX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ImmVirX is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ImmVirX is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ImmVirX.
ImmVirX financials insights
Gather financial insights about ImmVirX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$22M
2023
Series B
$25M
ImmVirX Tech Stack
A closer look at the technologies used by ImmVirX
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
ImmVirX News & Media
Biotech ImmVirX bucks VC desert to bank raise at $75m valuation - AFR
The company’s virus targets and kills colorectal, gastric or ovarian cancer cells before multiplying and releasing particles to destroy the remaining tumour.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding ImmVirX
Sign Up For FreeTo access detailed company insights
ImmVirX is a provider of immuno-oncology company using proprietary bio-selected RNA viruses that target specific receptor proteins highly expressed on a range of cancer cell types, allowing them to selectively enter, replicate in, and destroy tumor cells while creating beneficial changes in the tumor micro-environment.... Read More
